These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37663369)

  • 1. Force, alternate movements, snap, suction and vibration functions of tongue are altered in oral submucous fibrosis patients.
    Sengupta N; Sarode SC; Sarode GS; Anand R; Mehta V
    J Oral Biol Craniofac Res; 2023; 13(5):657-661. PubMed ID: 37663369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Clinical Features in Oral Submucous Fibrosis: A 9-Year Retrospective Study.
    Sharma SR; Chavan S; Karjodkar FR; Sansare K; Bharathi S; Singh S
    Ethiop J Health Sci; 2022 Jan; 32(1):137-144. PubMed ID: 35250225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Evaluation of Eustachian Tube Changes in Oral Submucous Fibrosis Patients.
    Pottam A; Dharmana L; Ajit D; Ramakrishna BB; Vaddeswarapu RM; Lokesh KV
    Cureus; 2023 May; 15(5):e39040. PubMed ID: 37323366
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study.
    Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
    J Microsc Ultrastruct; 2023; 11(2):75-80. PubMed ID: 37448822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoexpression of alpha smooth muscle actin correlates with serum transforming growth factor-β1 levels in oral submucous fibrosis.
    Singh I; Juneja S; Tandon A; Jain A; Shetty DC; Sethi A
    J Investig Clin Dent; 2019 Nov; 10(4):e12473. PubMed ID: 31631564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary malondialdehyde in oral submucous fibrosis - A marker for oxidative damage.
    Ganta SR; Chittemsetti S; Sravya T; Guttikonda VR
    J Oral Maxillofac Pathol; 2021; 25(1):82-87. PubMed ID: 34349416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spirulina and pentoxyfilline - a novel approach for treatment of oral submucous fibrosis.
    Mulk BS; Deshpande P; Velpula N; Chappidi V; Chintamaneni RL; Goyal S
    J Clin Diagn Res; 2013 Dec; 7(12):3048-50. PubMed ID: 24551724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of mast cells and burning sensation in various stages of Oral Submucous Fibrosis.
    Kumar LB; Mathew P; Madhavan N; Siddique S; Kshetrimayum N; Iyer K
    J Oral Biol Craniofac Res; 2020; 10(4):430-434. PubMed ID: 32793410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell expression in oral submucous fibrosis: A systematic review and metanalysis.
    Gharote H; Bhowate R
    J Clin Exp Dent; 2023 Jul; 15(7):e571-e577. PubMed ID: 37519326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Therapeutic Efficacy of Different Treatment Modalities in Oral Submucous Fibrosis: A Comparative Study.
    Tp B; T AG; Varghese M; Raghavan R; Vm MN; Pius A
    J Contemp Dent Pract; 2019 Mar; 20(3):390-394. PubMed ID: 31204333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of role of trace elements in oral submucous fibrosis patients: A study on Gujarati population.
    Jani YV; Chaudhary AR; Dudhia BB; Bhatia PV; Soni NC; Patel PS
    J Oral Maxillofac Pathol; 2017; 21(3):455. PubMed ID: 29391727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Stage Oral Submucous Fibrosis is Characterized by Increased Vascularity as Opposed to Advanced Stages.
    Tekade SA; Chaudhary MS; Tekade SS; Sarode SC; Wanjari SP; Gadbail AR; Wanjari PV; Gawande MN; Korde-Choudhari S; Zade P
    J Clin Diagn Res; 2017 May; 11(5):ZC92-ZC96. PubMed ID: 28658917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
    Choudhari S; Masne S; Bhandare P; Dhumal S
    J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of serum immunoglobulin G and immunoglobulin A levels in oral submucous fibrosis patients.
    Swami AN; Kale LM; Choudhary SH; Singh AK; Aldhuwayhi SD; Thakare A
    Natl J Maxillofac Surg; 2022; 13(1):67-71. PubMed ID: 35911796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Gustatory Function in Oral Submucous Fibrosis Patients and Gutka Chewers.
    Bangi BB; Ginjupally U; Nadendla LK; Mekala MR; B JL; Kakumani A
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):569-573. PubMed ID: 30803222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Velar morphological variants in oral submucous fibrosis: A comparative digital cephalometric study.
    Patil BM; Ara SA; Katti G; Ashraf S; Roohi U
    Indian J Dent Res; 2017; 28(6):623-628. PubMed ID: 29256459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
    Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
    J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
    Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
    J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Oral Submucous Fibrosis on Quality of Life: A Cross-Sectional Study.
    Chaudhry K; Bali R; Patnana AK; Bindra S; Jain G; Sharma PP
    J Maxillofac Oral Surg; 2019 Jun; 18(2):260-265. PubMed ID: 30996549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.
    Chaudhary M; Bajaj S; Bohra S; Swastika N; Hande A
    J Oral Maxillofac Pathol; 2015; 19(2):122-7. PubMed ID: 26604484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.